Q J Med 1999; 92: 623-629
© 1999 Association of Physicians
Review |
Tilt table testing in the diagnosis of unexplained syncope
From the Cardiovascular Investigation Unit, Department of Geriatric Medicine, Royal Victoria Infirmary, Newcastle, UK
Professor R.A. Kenny, Cardiovascular Investigation Unit, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP. e-mail: r.a.kenny{at}ncl.ac.uk
| Introduction |
|---|
|
|
|---|
While the investigation of the physiological and pathophysiological effects of orthostatic stress induced by head-up tilt table testing in humans began more than 50 years ago,1 it was not until 1986 that the utility of tilt testing in the diagnosis of unexplained syncope was demonstrated.2 In the absence of a `gold-standard' diagnostic test for vasovagal syncope, an appropriate clinical history in association with a positive head-up tilt test currently provides the cornerstone for the diagnosis of vasovagal syncope.3 This article will provide an overview of the rationale for the head-up tilt test in relation to its main diagnostic use, vasovagal syncope, a discussion of the methodological issues surrounding the test and the uses of tilt table testing in the further differential diagnosis of unexplained syncope.
| Vasovagal syncope and the pathophysiological rationale for head-up tilt testing |
|---|
|
|
|---|
More than 60 years after the introduction of the term `vasovagal syncope' by Lewis,4 the exact mechanisms responsible for loss of consciousness associated with profound hypotension and/or bradycardia, and mediated by vagal excess and sympathetic withdrawal, remain uncertain. The main trigger factors for the vasovagal cascade can be divided into central and peripheral provocateurs,5 with the latter providing the substrate for the diagnostic use of the tilt table. Head-up tilt table testing provides a powerful, controlled orthostatic stimulus simulating under laboratory conditions the peripheral provocation of vasovagal syncope. The pathophysiology of the vasovagal response is thus central to an understanding of the role of tilting in its diagnosis.
Although central, higher cortical provocation of vasovagal syncope through emotional stress6 and pain7 is a clinical commonplace, the neuronal connections mediating the response are far from certain. Animal models implicate the limbic system as the relay region for stress-related neuronal activity,7,8 with the ultimate control mechanisms residing in hypothalamic and brain-stem autonomic nuclei.9 Human vasovagal syncope tends to present more prosaically, with many episodes following periods of prolonged standing, for example in church or in shopping queues. This observation led to the hypothesis that defective neurocardiovascular compensatory mechanisms during orthostatic stress were responsible for the initiation of the vasovagal cascade through an inappropriate Bezold-Jarisch-type reflex.10,11 Exaggerated venous pooling in capacitance vessels in the lower part of the body12 is thought to provoke relative central hypovolaemia7 with compensatory vigorous left ventricular contraction and sympathetic stimulation, resulting in inappropriate mechanoreceptor activation.1315 The resultant afferent traffic is then relayed via unmyelinated vagal C-fibres to the nucleus tractus solitarius of the medulla16 which orchestrates the efferent limb of the vasovagal response by undetermined mechanisms. Further support for this hypothesis is derived from the echocardiographic demonstration of vigorous left ventricular contractions15 and relatively low ventricular volumes17 in patients with tilt-induced syncope, but the demonstration of classic vasovagal syncope in orthotopic heart transplant recipients without evidence of vagal reinnervation18 provides a cautionary note, suggesting that the exact mechanisms responsible for the vasovagal neurocardiovascular cascade have yet to be fully elucidated.
The head-up tilt table test therefore mimics the orthostatic stress, resulting in maximal venous pooling, central hypovolaemia and peripheral provocation of vasovagal syncope. While the initial response to the assumption of the upright posture is similar in healthy subjects and syncopal patients, namely maintenance of arterial normotension through increasing cardiac inotropy and chronotropy and vasoconstriction of splanchnic and skeletal vascular beds,7,19,20 patients eventually exhibit the hallmark clinical and neurocardiovascular features of the vasovagal event. The fact that the tilt-induced syncopal episode is analogous to spontaneous attacks is evidenced by the similarity of symptoms leading up the event and the identical sequence of haemodynamic and neuroendocrine changes,3,21 in particular the dramatic arterial hypotension (with or without bradycardia/asystole) and catecholamine surge22 just before syncope.
| Indications and contraindications |
|---|
|
|
|---|
Head-up tilt table testing is indicated in the diagnosis of recurrent syncope where initial history, clinical examination and appropriate neurological and cardiovascular investigations have been non-diagnostic. Tilt-table testing may also be appropriate in patients with single syncopal episodes who have sustained injuries during attacks or who have experienced syncope while driving. Tilt testing may also be useful in the assessment of older patients with unexplained falls.21 Relative contraindications include proximal coronary artery stenosis, critical mitral stenosis, clinically severe left ventricular outflow obstruction and known severe cerebrovascular stenosis.3
| Methodology of the head-up tilt table test |
|---|
|
|
|---|
Equipment, monitoring and environment
The tilt table should be of the foot-plate support type, and whether mechanically or electrically powered, should be able to achieve the upright posture within 15 s3 and allow calibrated tilt angles of between 60° and 80° (Figure 1
|
Electrocardiographic monitoring should occur continuously during symptoms or haemodynamic changes and every 5 min otherwise. Blood pressure monitoring should ideally be of the continuous, non-invasive variety (e.g. digital photoplethysmography,23 Finapres) though sphygmomanometric measures are widely used. Blood pressure should similarly be recorded continuously (or as frequently as is practicable) during symptoms and at 1-min intervals otherwise. In order to minimize stimuli affecting autonomic nervous function, the test should occur in a quiet, dimly lit room at a comfortable temperature.8 Resuscitation equipment should be immediately available, and to the standard required in exercise tolerance testing facilities.3 The test should be continuously supervised by a physician, nurse or technician experienced in the management of the test and its potential complications.3
Patient preparation
Patients should be fasted for 2 or more hours prior to the procedure (in order to minimize the confounding effects of post-prandial orthostatic hypotension24) and then rested supine for 20 to 45 min,25 with longer periods necessary if intravascular instrumentation (which increases the risk of false positive results25,26) is used. The procedure should be explained to the patient, who should be securely strapped to the tilt table prior to the assumption of the upright position to prevent collapse and injury during syncope. Drugs affecting cardiovascular or autonomic function should be discontinued for a minimum of five half-lives pre-test, unless they are aetiologically implicated.3 During the test the patient should be instructed to avoid movements of the lower extremities to maximize venous pooling.3,24
Tilt angle and duration of the head-up tilt test
The angle and duration of the test are the most powerful determinants of its diagnostic utility. The evidence available to date suggests that tilt angles between 60° and 80° are optimal in creating sufficient orthostatic stress without increasing the number of false positive or negative results.3,2730 The duration of the test also varies between centres, but the available evidence suggests that prolonged tilt for 3045 min is optimal,3,2830 with longer periods engendering unacceptably high proportions of false positive results.55 Our own practice uses a 70° tilt angle for 40 min.
Sensitivity and specificity of the head-up tilt table test
These issues were touched upon in the previous section, but deserve closer attention. The absence of a `gold-standard' diagnostic test for vasovagal syncope makes the calculation of the exact specificity and sensitivity of the tilt test difficult, particularly in view of the variable methodologies used by different groups reporting results. The ability of the test to differentiate patients from healthy controls is nonetheless well established, with specificity generally up to 90% at tilt angles between 60° and 70°, and sensitivity ranging between 32% and 85%, with the median closer to the upper number.3,28,3234 These figures compare well with standard cardiological diagnostic tests, including the 12-lead ECG and exercise testing.33
Reproducibility of the head-up tilt table test
Reproducibility studies on the responses to head-up tilt table testing have produced some contradictory results. Long-term reproducibility, from periods of 1 day35 to 4 years36 have generally shown reproducible responses in 62% to 85% of subjects,3538 although one report found 1-day reproducibility to be as low as 35%.39 Repeated testing within 30 min shows consistently concordant responses in 67%40 to 87%41 of the patients studied, though several studies report marked intra-individual variability in the degrees of cardioinhibition and vasodepressor components to the vasovagal responses elicited.4143
Positivity of the head-up tilt table test
The head-up tilt table test should only be judged positive if symptoms reproducing entirely the patients original pre-syncopal or syncopal symptoms are accompanied by arterial hypotension, bradycardia or both.3,28,44 Haemodynamic changes in isolation should not prompt a diagnosis of vasovagal syncope.
Pharmacological provocative agents in head-up tilt table testing
Provocative agents to both shorten the duration and increase the specificity of the head-up tilt test have a well-established role in the diagnosis of vasovagal syncope. If the initial prolonged, drug-free tilt test is non-diagnostic, pharmacological provocateurs should be considered.
Isoproterenol
The observation of a catecholaminergic surge immediately prior to tilt-induced syncope in susceptible individuals22 prompted the administration of exogenous catecholamines to precipitate syncope in patients suspected of suffering from vasovagal syncope. Following the initial report by Almquist et al.,32 many centres have now reported improved sensitivity in the diagnosis of vasovagal syncope,27,32,43,45,46 though at the expense of a fall in specificity using high-dose regimens.45,47 Isoproterenol tilt is safe, with few adverse events reported, though recent data from our group has shown that the procedure is poorly tolerated in older subjects.48 Contraindications to isoproterenol include coronary artery disease, uncontrolled hypertension, significant aortic stenosis and left ventricular outflow obstruction, and the drug should be used with caution in subjects with known supraventricular or ventricular arrhythmias.
Nitrates
Nitrates have been used as provocative agents in the tilt-table aided diagnosis of vasovagal syncope for several years. Their venodilatory properties are thought to promote the syncopal cascade through the peripheral route. Glyceryl trinitrate in both intravenous49 and sublingual31,5052 preparations has been used for 2030 min following an initial drug-free passive tilt. Sensitivity ranges from 51 to 81%, and specificity from 85% to 94%.61,65,85,86 Our own recent data shows comparable specificity and sensitivity with both passive and isoproterenol tilts,48 with the added benefits of ease of administration, relative lack of side-effects and the avoidance of intra-vascular instrumentation, which is known to affect specificity adversely.25,26
Other pharmacological provocative agents
The endogenous nucleoside adenosine, which enhances sympathetic nervous activity53 and promotes vasodilatation,54 has been used to shorten the duration of tilt testing with some success in several small studies.55 Edrophonium56 and clomipramine57 have also been used to accelerate the tilt table test with some success, though the methods need further assessment before their widespread adoption.
| Classification of vasovagal syncope |
|---|
|
|
|---|
Positive responses to tilt testing can be divided into four subgroups based on specific patterns of heart rate and blood pressure changes during syncope58 and these are described in Table 1
|
| Head-up tilt table testing at the extremes of age |
|---|
|
|
|---|
Tilt table testing has been reported at all ages at which prolonged standing is practicable, with subjects as young as 3 years being described.59 Indications, contraindications and methodology are essentially the same in paediatric60,61 and elderly25,31,48,62 subjects, with the proviso that isoproterenol dosage should not exceed 0.03 µg/kg in children.44 Elderly patients often have sudden onset syncope with little or no prodrome,63 so positivity criteria need to be viewed with this in mind. Isoprenaline is more often contraindicated in this age-group because of associated co-morbidity and more pronounced side-effects.48 Recent data from our group shows GTN tilt to be well-tolerated in older subjects undergoing provoked tilt, with no effects on sensitivity and specificity.48
| Further differential diagnosis of unexplained syncope using tilt table testing |
|---|
|
|
|---|
A summary of the alternative differential diagnoses achievable with tilt-testing is given in Table 2
|
| References |
|---|
|
|
|---|
1. Allen SC, Taylor CL, Hall VE. A study of orthostatic insufficiency by the tiltboard method. Am J Physiol 1945; 143:11.
2. Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986; 1:13524.[Web of Science][Medline]
3. Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, et al. Tilt table testing for assessing syncope. ACC Expert Consensus Document. J Am Coll Cardiol 1996; 28:26375.[Web of Science][Medline]
4.
Lewis T. Vasovagal syncope and the carotid sinus mechanism. With comments on Gower's and Nothnagels syndrome. Br Med J 1932; 1:8736.
5. Parry SW, Kenny RA. Tilt table testing. In: Malik M, ed. Clinical Guide to Cardiac Autonomic Tests. Amsterdam, Kluwer Academic Publishers, 1998:6799.
6. Greenfield ADM. An emotional faint. Lancet 1951; 1:13023.
7. Weiling W, Smit AAJ, De Jong-De Vos Van Steenwijk CCE, Van Lieshout JJ, Karemaker JM. Pathophysiological mechanisms underlying vasovagal syncope in young subjects. Pacing Clin Electrophysiol 1997; 20:20348.[Medline]
8. Koizumi K, Kollai M. Control of reciprocal and non-reciprocal action of vagal and sympathetic efferents: study of centrally induced reactions. J Auton Nerv Syst 1981; 3:483501.[Web of Science][Medline]
9. Le Doux JE. Emotion and the amygdala. In: Aggleton JP, ed. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, New York, Wiley-Liss, 1992:33951.
10. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983; 1:90102.[Abstract]
11. Coleridge HM, Coleridge JCG, Kidd C. Cardiac receptors in the dog, with reference to two types of afferent endings in the ventricular wall. J Physiol (Lond) 1964; 174:3239.
12.
Epstein SE, Stampfer M, Beiser GD. Role of the capacitance and resistance vessels in vasovagal syncope. Circulation 1968; 37:52433.
13. Kaufman H. Neurally mediated syncope and syncope due to autonomic failure: differences and similarities. J Clin Neurophysiol 1997; 14:18396.[Web of Science][Medline]
14. Oberg B, Thoren P. Increased activity in left ventricular receptors during haemorrhage or occlusion of caval veins in the cat. A possible cause of the vasovagal reaction. Acta Physiol Scand 1972; 85:16473.[Web of Science][Medline]
15. Shalev Y, Gal R, Tchou PJ, Anderson AJ, Avitall B, Akhtar M, et al. Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt. J Am Coll Cardiol 1991; 18:74651.[Abstract]
16. Seller H. Central baroreceptor reflex pathways. In: Persson PB, Kircheim HR, eds. Baroreceptor Reflexes. Berlin, Springer Verlag, 1991:4574.
17. Fitzpatrick A, Williams T, Ahmed R, Lightman S, Bloom SR, Sutton R. Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. Eur J Cardiac Pacing Electrophysiol 1992; 2:1218.
18. Scherrer U, Vissing S, Morgan BJ, Hanson P, Victor RG. Vasovagal syncope after infusion of a vasodilator in a heart transplant recipient. N Engl J Med 1990; 322:6024.[Web of Science][Medline]
19. Hainsworth R, al Shamma YMH. Cardiovascular responses to upright tilting in healthy subjects. Clin Sci 1988; 74:1722.[Medline]
20. Sneddon JF, Counihan PJ, Bashir Y, Haywood GA, Ward DE, Camm AJ. Impaired immediate vasoconstrictor responses in patients with recurrent neurally mediated syncope. Am J Cardiol 1993; 71:726.[Web of Science][Medline]
21. Grubb BP, Samoil D. Neurocardiogenic syncope. In: Kenny RA, ed. Syncope in the Older Patient: Causes, Investigations and Consequences of Syncope and Falls. London, Chapman & Hall, 1996:91106.
22. Sra JS, Murthy V, Natale A, Jazayeri MR, Dhala A, Deshpaned S, et al. Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncope. Am J Cardiol 1994; 73:337.[Web of Science][Medline]
23. Jellema WT, Imholz BPM, Van Goudoever J, Wesseling KH, Van Lieshout J. Finger arterial versus intrabrachial pressure and continuous cardiac output during head-up tilt testing in healthy subjects. Clin Sci 1996; 91:193200.[Medline]
24. Victor J. Tilt Test: environment, material, patient preparation. In: Blanc JJ, Benditt D, Sutton R, eds. Neurally Mediated Syncope: Pathophysiology, Investigations, and Treatment. The Bakken Research Center Series Vol. 10. Armonk, NY, Futura, 1996:778.
25.
McIntosh SJ, Lawson J, Kenny RA. Intravenous cannulation alters the specificity of head-up tilt testing for vasovagal syncope in elderly patients. Age Ageing 1994; 23:31719.
26. Stevens PM. Cardiovascular dynamics during orthostasis and the influence of intravascular instrumentation. Am J Cardiol 1966; 17:21118.[Web of Science][Medline]
27. Blanc J, Victor J, Mansourati J, Le Davay M, Dupuis J-M, Maheu B. Accuracy and mean duration of different protocols of head-up tilt testing. Am J Cardiol 1996; 77:31013.[Web of Science][Medline]
28. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head upright tilt table testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17:12530.[Abstract]
29. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head upright tilt table testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17:12530.
30. Fitzpatrick A, Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989; 1:65870.[Web of Science][Medline]
31. McIntosh S, Lawson J, da Costa D, Kenny RA. Use of sublingual glyceryl trinitrate during head-up tilt as a provocative test for vasovagal responses in elderly patients with unexplained syncope. Cardiol Elderly 1996; 4:337.
32. Almquist A, Goldenberg IF, Milstein S, Chen M-Y, Chen X, Hansen R, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989; 320:34651.[Abstract]
33. Benditt DG. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. Pacing Clin Electrophysiol 1997; 20:57284.[Medline]
34. Fouad FM, Sitthisook S, Vanerio G, Maloney J, Okabe M, Jaeger F, et al. Sensitivity and specificity of the tilt table test in young patients with unexplained syncope. Pacing Clin Electrophysiol 1993; 16:394400.[Medline]
35. Raviele A, Gasparini G, DiPede F, Delise P, Bonso A, Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 1990; 65:13227.[Web of Science][Medline]
36. Petersen MEV, Price D, Williams T, Jensen N, Riff K, Sutton R. Short AV interval VDD pacing does not prevent tilt induced vasovagal syncope in patients with cardioinhibitory vasovagal syndrome. Pacing Clin Electrophysiol 1994; 17:88291.[Medline]
37. Blanc JJ, Mansourati J, Maheu B, Boughaleb D, Genet L. Reproducibility of a positive passive upright tilt test at a seven-day interval in patients with syncope. Am J Cardiol 1993; 72:46971.[Web of Science][Medline]
38. Sheldon R, Splawinski J, Killam S. Reproducibility of upright tilt-table tests in patients with syncope. Am J Cardiol 1992; 69:13005.[Web of Science][Medline]
39. Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA. Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993; 72:128992.
40. Fish FA, Strasburger JF, Woodrow Benson D. Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope. Am J Cardiol 1992; 70:6059.[Web of Science][Medline]
41. Chen XC, Chen MY, Remole S, Kobayashi Y, Dunnigan A, Milstein S, et al. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol. 1992; 69:75560.[Web of Science][Medline]
42. De May C, Enterling D. Variant responses impair the usefulness of passive upright tilt in drug research. Methods Find Exp Clin Pharmacol 1988; 10:5764.[Web of Science][Medline]
43. Morillo CA, Klein GJ, Zandri S, Yee R. Diagnostic accuracy of a low dose isoproterenol head-up tilt protocol. Am Heart J 1995; 129:9016.[Web of Science][Medline]
44. Davies R, Slater JDH, Forsling ML. The response of arginine vasopressin and plasma renin to postural change in normal man, with observations on syncope. Clin Sci 1976; 51:26774.
45. Carlioz R, Graux P, Haye J, Letourneau T, Guyomar Y, Hubert E, et al. Prospective evaluation of high dose and low dose isoproterenol upright tilt protocol for unexplained syncope in young adults. Am Heart J 1997; 133:34652.[Web of Science][Medline]
46. Waxman MB, Yao L, Cameron D, Wald RW, Roseman J. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol 1989; 63:5865.[Web of Science][Medline]
47.
Fitzpatrick AP, Lee RJ, Epstein LM, Lesh MD, Eisenberg S, Scheinman MM. Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation. Heart 1996; 76:40611.
48. Graham L, Kenny RA. Comparison of intravenous isoprenaline and sublingual glyceryl trinitrate for provocation of vasovagal syncope during tilt table testinga randomised controlled trial. Pacing Clin Electrophysiol 1998; 21 (4 part II):793, A14.
49. Raviele A, Gasparini G, Di Pede F, Menozzi C, Brignole M, Dinelli M, et al. Nitroglycerine infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J 1994; 127:10311.[Web of Science][Medline]
50. Ammirati F, Colvicchi F, Biffi A, Magris B, Pandozi C, Santini M. Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: A simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J 1998; 135:6716.[Web of Science][Medline]
51. Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerine to assess the origin of unexplained syncope. Am J Cardiol 1995; 76:26772.[Web of Science][Medline]
52. Aerts A, Dendale P, Strobel G, Block P. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope. Am Heart J 1997; 133:5047.[Web of Science][Medline]
53.
Biaggioni I, Killian TJ, Mosqueda-Garcia R, Robertson RM, Robertson D. Adenosine increases sympathetic nerve traffic in humans. Circulation 1991; 83:166875.
54.
Tseng C-G, Biaggioni B, Appalsamy M, Robertson D. Purinergic receptors in the brainstem mediate hypotension and bradycardia. Hypertension 1988; 11:1917.
55. Shen W-K, Hammill SC, Munger TM, Stanton MS, Packer DL, Osborn MJ, et al. Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol 1996; 28:14654.[Abstract]
56. Lurie KG, Dutton J, Mangat R, Newman D, Eisenberg S, Scheinman M. Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing. Am J Cardiol 1993; 72:128690.[Web of Science][Medline]
57. Flevari P, Theodorakis GN, Zarvaliss E, Livanis E, Mesiskli T, Kremastinos DT. Head-up tilt test after clomipramine challenge in neurally mediated syncope patients. Pacing Clin Electrophysiol 1998; 21 (4 part II):793, A13.
58. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992; 3:1803.
59. Grubb BP, Orecchio E, Kurczynski TW. Head-upright tilt table testing in evaluation of recurrent unexplained syncope. Paediatr Neurol 1992; 8:4237.[Web of Science][Medline]
60.
Thilenius OG, Quinones JA, Huusayni TS, Novak J. Tilt test for diagnosis of unexplained syncope in paediatric patients. Pediatrics 1991; 87:3348.
61. Lerman-Sagie T, Rechavia E, Strasberg B, Sagie A, Blieden L, Mimouni M. Head-up tilt for the evaluation of syncope of unknown origin in children. J Pediatr 1991; 118:6769.[Web of Science][Medline]
62.
Lipsitz LA, Marks ER, Koestner J, Jonsson PV, Wei JY. Reduced susceptibility to syncope during postural tilt in old age. Is beta-blockade protective? Arch Intern Med 1989; 149:270912.
63. Sutton R. Vasovagal syncope: clinical features, epidemiology and natural history. In: Blanc JJ, Benditt D, Sutton R, eds. Neurally Mediated Syncope: Pathophysiology, Investigations, and Treatment. The Bakken Research Center Series Vol. 10 Armonk NY, Futura, 1996:716.
64. Petersen MEV, Williams TR, Sutton R. Psychogenic syncope diagnosed by prolonged head-up tilt testing. Q J Med 1995; 88:20913.
65.
Naschitz JE, Gaitini L, Mazov L, Eridzhanyan D, Keren E, Sabo D, Yeshurun D, Hardoff D, Jaffe M. The capnography-tilt test for the diagnosis of hyperventilation syncope. Q J Med 1997; 90:13945.
66. Grubb BP, Kosinski DJ, Boehm K, Kip K. The postural orthostatic tachycardia syndrome. A neurocardiogenic variant identified during head-up tilt table testing. Pacing Clin Electrophysiol 1997; 20:220512.[Medline]
67. Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Neurol Sci 1996; 144:21819.[Web of Science][Medline]
68. Grubb BP, Ferard G, Roush K, Temesy-Armos P, Elliott L, Hahn H, et al. Differentiation of convulsive syncope and epilepsy with head-up tilt table testing. Ann Intern Med 1991; 115:8716.
69.
Zaidi A, Clough P, Scheepers B, Fitzpatrick A. Treatment resistant epilepsy or convulsive syncope. Br Med J 1998; 317:86970.
70. Kenny RA, McIntosh SJ. Carotid sinus syndrome. In: Kenny RA, ed. Syncope in the Older Patient: Causes, Investigations and Consequences of Syncope and Falls. London, Chapman & Hall, 1996:10722.
71. Hammill SC, Holmes DR, Wood DL. Electrophysiologic testing in the upright position: improved evaluation of patients with rhythm disturbance using a tilt table. J Am Coll Cardiol 1984; 4:6571.[Abstract]
72. McIntosh SJ, Lawson J, Kenny RA. Clinical characteristics of vasodepressor, cardioinhibitory and mixed carotid sinus syndrome in the elderly. Am J Med 1993; 95:2038.[Web of Science][Medline]
73. Parry SW, Richardson DA, O'Shea D, Kenny RA. Diagnosing carotid sinus hypersensitivity: carotid sinus massage upright is essential. Pacing Clin Electrophysiol 1998; 21:805, A62.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. W. Parry, J. C. Gray, J. L. Newton, P. Reeve, D. O'shea, and R. A. Kenny 'Front-loaded' head-up tilt table testing: validation of a rapid first line nitrate-provoked tilt protocol for the diagnosis of vasovagal syncope Age Ageing, July 1, 2008; 37(4): 411 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J L Hampton, S W Parry, R A Kenny, and J L Newton Lower 24 hour urinary sodium concentrations are associated with more severe symptoms in subjects with vasovagal syncope Heart, June 1, 2004; 90(6): 687 - 688. [Full Text] [PDF] |
||||
![]() |
P. E M Smith IF IT'S NOT EPILEPSY . . . J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(suppl_2): ii9 - ii14. [Full Text] [PDF] |
||||
![]() |
S.W. Parry and R.A. Kenny The management of vasovagal syncope QJM, December 1, 1999; 92(12): 697 - 705. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




